ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

APRE Aprea Therapeutics Inc

6.06
-0.01 (-0.16%)
Last Updated: 09:32:07
Delayed by 15 minutes

Period:

Draw Mode:

Volume 222
Bid Price 5.91
Ask Price 6.06
News -
Day High 6.06

Low
2.78

52 Week Range

High
8.8465

Day Low 6.06
Company Name Stock Ticker Symbol Market Type
Aprea Therapeutics Inc APRE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.01 -0.16% 6.06 09:32:07
Open Price Low Price High Price Close Price Prev Close
6.06 6.06 6.06 6.07
Trades Volume Avg Volume 52 Week Range
15 222 - 2.78 - 8.8465
Last Trade Time Type Quantity Stock Price Currency
09:32:07 2 $ 5.98 USD

Aprea Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
22.68M 3.74M - 0 -112.66M -30.15 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Aprea Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No APRE Message Board. Create One! See More Posts on APRE Message Board See More Message Board Posts

Historical APRE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week6.676.675.886.2118,902-0.61-9.15%
1 Month7.348.84655.056.7376,439-1.28-17.44%
3 Months5.288.84654.82016.5537,0290.7814.77%
6 Months4.008.84653.355.9723,5342.0651.50%
1 Year4.688.84652.784.6526,5481.3829.49%
3 Years101.00156.002.7881.18656,527-94.94-94.00%
5 Years309.201,062.202.78118.74571,589-303.14-98.04%

Aprea Therapeutics Description

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).

Your Recent History

Delayed Upgrade Clock